PHASE I/II STUDY LADARIXIN AND SOTORASIB IN ADVANCED KRAS G12C MUTANT NON-SMALL CELL LUNG CANCER (NSCLC).



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.